Table 2.
Choroid and RNFL thickness values of the COPD and control groups.
| Group A (n=30) | Group B (n=30) | Control (n=23) | p | p ∗ | p ∗∗ | p ∗∗∗ | |
|---|---|---|---|---|---|---|---|
| SFCT | 228.3 ± 76.2 | 224.3 ± 78.7 | 269.0 ± 86.7 | 0.016K | 0.813 | 0.047 | 0.046 |
| N | 207.6 ± 82.1 | 208.3 ± 85.3 | 216.9 ± 64.3 | 0.455K | 0.976 | 0.170 | 0.414 |
| T | 204.6 ± 66.9 | 213.6 ± 67.1 | 218.9 ± 66.9 | 0.611K | 0.487 | 0.389 | 0.596 |
| RSLT | 103.0 ± 11.4 | 98.3 ± 11.3 | 100.1 ± 9.4 | 0.263K | 0.113 | 0.265 | 0.767 |
Group A: COPD at the exacerbation period; Group B: COPD at the stable period; SFCT: subfoveal choroidal thickness; N: nasal choroid; T: temporal choroid; RNFL: retinal nerve fiber layer; KKruskal–Wallis; ∗p: between Groups A and B; ∗∗p: between Group A and controls; ∗∗∗p: between Group B and controls.